BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1680611)

  • 1. BCR rearrangements in Ph positive chronic myelocytic leukemia.
    Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
    Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
    Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
    Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
    Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
    Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemia.
    Tesch H; Fonatsch C; Diehl V
    In Vivo; 1991; 5(3):233-8. PubMed ID: 1893079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
    Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
    Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic and molecular aspects of Ph-positive leukemia].
    Misawa S; Nishigaki H
    Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rearrangement and expression of bcr-abl genes in CML and ALL].
    Kunieda Y; Okabe M
    Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
    Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia.
    Ge X; Tanaka K; Kamada N
    Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Philadelphia chromosome positive acute mixed lineage leukemia with bcr (M-BCR-1) rearrangement].
    Okada S; Shimizu T; Harada H; Miyoshi Y; Takizawa Y; Hagiwara S; Mori H; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1990 Jan; 31(1):89-94. PubMed ID: 2156095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.